Evolus Reports Record Fourth Quarter and Full-Year 2024 Financial Results; Reaffirms 2025 Guidance

Go back to Evolus Reports Record Fourth Quarter and Full-Year 2024 Financial Results; Reaffirms 2025 Guidance
(NASDAQ: EOLS) Delayed: 7.99 +0.13 (1.65%)
Previous Close $7.86    52 Week High
Open $7.93    52 Week Low
Day High $8.00    P/E N/A 
Day Low $7.76    EPS
Volume 420,741